Bioventus Future Growth
Future criteria checks 3/6
Bioventus is forecast to grow earnings and revenue by 182.6% and 6.4% per annum respectively. EPS is expected to grow by 119.8% per annum. Return on equity is forecast to be 15.1% in 3 years.
Key information
182.6%
Earnings growth rate
119.8%
EPS growth rate
| Medical Equipment earnings growth | 17.1% |
| Revenue growth rate | 6.4% |
| Future return on equity | 15.1% |
| Analyst coverage | Low |
| Last updated | 06 Nov 2024 |
Recent future growth updates
Recent updates
Healing Numbers, Hurting Valuation: Bioventus' Mixed Bag In Q2 2024
Aug 12Bioventus: Bullish On Path To Profitability
Jan 24Bioventus: Reiterating Buy Thesis Following Q2 Earnings
Sep 08Bioventus Non-GAAP EPS of $0.10 misses by $0.06, revenue of $140.3M beats by $1.97M
Aug 11Bioventus stock rises as FDA clears SonaStar Elite for use in tumor removal
Aug 03Bioventus: Strong Value Gap, Insulated Via Leading Market Share
Jun 14Bioventus: Thoughts After An Active First Year
Mar 29Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 640 | N/A | 90 | 69 | 2 |
| 12/31/2025 | 602 | 7 | 102 | 93 | 3 |
| 12/31/2024 | 564 | -8 | 24 | 8 | 3 |
| 9/28/2024 | 555 | -39 | 28 | 30 | N/A |
| 6/29/2024 | 537 | -42 | 8 | 11 | N/A |
| 3/30/2024 | 523 | -22 | 2 | 7 | N/A |
| 12/31/2023 | 512 | -97 | 8 | 15 | N/A |
| 9/30/2023 | 503 | -104 | 0 | 10 | N/A |
| 7/1/2023 | 511 | -169 | 8 | 18 | N/A |
| 4/1/2023 | 514 | -173 | -1 | 10 | N/A |
| 12/31/2022 | 512 | -104 | -24 | -14 | N/A |
| 10/1/2022 | 517 | -91 | -15 | -6 | N/A |
| 7/2/2022 | 497 | -19 | -4 | 6 | N/A |
| 4/2/2022 | 466 | -16 | 11 | 20 | N/A |
| 12/31/2021 | 431 | -5 | 9 | 23 | N/A |
| 10/2/2021 | 399 | -3 | 29 | 35 | N/A |
| 7/3/2021 | 376 | 6 | 40 | 46 | N/A |
| 4/3/2021 | 324 | 4 | 31 | 36 | N/A |
| 12/31/2020 | 321 | 16 | 55 | 72 | N/A |
| 9/26/2020 | 320 | 16 | 71 | 67 | N/A |
| 6/27/2020 | 316 | 12 | 62 | 58 | N/A |
| 3/28/2020 | 339 | 15 | 55 | 54 | N/A |
| 12/31/2019 | 340 | 9 | 38 | 41 | N/A |
| 12/31/2018 | 319 | -1 | 43 | 45 | N/A |
| 4/2/2016 | 266 | -23 | N/A | 25 | N/A |
| 12/31/2015 | 254 | -38 | N/A | 19 | N/A |
| 12/31/2014 | 243 | -17 | N/A | 15 | N/A |
| 12/31/2013 | 232 | -26 | N/A | 3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BVS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: BVS is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: BVS is expected to become profitable in the next 3 years.
Revenue vs Market: BVS's revenue (6.4% per year) is forecast to grow slower than the US market (9% per year).
High Growth Revenue: BVS's revenue (6.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BVS's Return on Equity is forecast to be low in 3 years time (15.1%).